Invesco Ltd. Novartis Ag Transaction History

Invesco Ltd.

$499 Billion
Q3 2024

A detailed history of Invesco Ltd. transactions in Novartis Ag stock. As of the latest transaction made, Invesco Ltd. holds 202,726 shares of NVS stock, worth $20.1 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

202,726

Previous 242,881 16.53%

Holding current value

$20.1 Million

Previous $25.9 Million 9.82%

% of portfolio

0.0%

Previous 0.01%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$106.13 - $120.89 $4.26 Million - $4.85 Million	-40,155 Reduced 16.53%	202,726 $23.3 Million
Q2 2024 Aug 13, 2024	BUY	$92.57 - $107.37 $14,626 - $16,964	158 Added 0.07%	242,881 $25.9 Million
Q1 2024 May 14, 2024	SELL	$95.27 - $108.47 $2.36 Million - $2.69 Million	-24,793 Reduced 9.27%	242,723 $23.5 Million
Q4 2023 Feb 12, 2024	SELL	$92.27 - $101.54 $2.53 Million - $2.78 Million	-27,427 Reduced 9.3%	267,516 $27 Million
Q3 2023 Nov 13, 2023	SELL	$94.73 - $105.13 $2.92 Million - $3.24 Million	-30,798 Reduced 9.45%	294,943 $30 Million
Q2 2023 Aug 11, 2023	SELL	$92.52 - $104.91 $6.68 Million - $7.57 Million	-72,152 Reduced 18.13%	325,741 $32.9 Million
Q1 2023 May 12, 2023	BUY	$80.03 - $92.81 $5.05 Million - $5.85 Million	63,069 Added 18.84%	397,893 $36.6 Million
Q4 2022 Feb 13, 2023	SELL	$75.55 - $92.52 $2.27 Million - $2.78 Million	-30,013 Reduced 8.23%	334,824 $30.4 Million
Q3 2022 Nov 14, 2022	BUY	$74.61 - $87.26 $2.48 Million - $2.9 Million	33,179 Added 10.0%	364,837 $27.7 Million
Q2 2022 Aug 15, 2022	BUY	$80.52 - $93.75 $320,791 - $373,500	3,984 Added 1.22%	331,658 $28 Million
Q1 2022 May 16, 2022	BUY	$80.11 - $90.62 $2.9 Million - $3.28 Million	36,184 Added 12.41%	327,674 $28.8 Million
Q4 2021 Feb 14, 2022	SELL	$79.7 - $88.13 $6.82 Million - $7.54 Million	-85,591 Reduced 22.7%	291,490 $25.5 Million
Q3 2021 Nov 15, 2021	SELL	$81.78 - $95.14 $11.2 Million - $13 Million	-136,799 Reduced 26.62%	377,081 $30.8 Million
Q2 2021 Aug 17, 2021	SELL	$85.24 - $94.15 $19.5 Million - $21.6 Million	-229,298 Reduced 30.85%	513,880 $46.9 Million
Q1 2021 May 17, 2021	SELL	$83.5 - $98.47 $19.5 Million - $23 Million	-233,124 Reduced 23.88%	743,178 $63.5 Million
Q4 2020 Feb 16, 2021	SELL	$78.07 - $94.43 $46.1 Million - $55.7 Million	-590,111 Reduced 37.67%	976,302 $92.2 Million
Q3 2020 Nov 16, 2020	SELL	$82.14 - $91.0 $2.77 Million - $3.07 Million	-33,766 Reduced 2.11%	1,566,413 $136 Million
Q2 2020 Aug 14, 2020	SELL	$80.93 - $91.1 $28.1 Million - $31.6 Million	-347,418 Reduced 17.84%	1,600,179 $140 Million
Q1 2020 May 15, 2020	SELL	$70.67 - $99.01 $2.75 Million - $3.85 Million	-38,908 Reduced 1.96%	1,947,597 $161 Million
Q4 2019 Feb 14, 2020	SELL	$84.35 - $95.37 $5.09 Million - $5.76 Million	-60,366 Reduced 2.95%	1,986,505 $188 Million
Q3 2019 Nov 14, 2019	SELL	$85.54 - $94.26 $15.3 Million - $16.9 Million	-178,778 Reduced 8.03%	2,046,871 $178 Million
Q2 2019 Aug 14, 2019	BUY	$75.4 - $92.8 $35.8 Million - $44 Million	474,241 Added 27.08%	2,225,649 $203 Million
Q1 2019 May 15, 2019	SELL	$75.32 - $86.15 $10.9 Million - $12.5 Million	-145,377 Reduced 7.66%	1,751,408 $168 Million
Q4 2018 Feb 14, 2019	BUY	$73.66 - $82.02 $140 Million - $156 Million	1,896,785 New	1,896,785 $163 Million

Others Institutions Holding NVS

# of Institutions

1,437

Shares Held

131M

Call Options Held

1.12M

Put Options Held

1.83M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $213B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.

Account